Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 15210898.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The clinical and neurophysiologic data from 65 patients taking thalidomide were reviewed. Thalidomide sensory neurotoxicity was found to be cumulative dose dependent but occurs only when the total dose is relatively high (>20 g). The risk of developing sensory neuropathy is around 10% below this threshold but increases with higher doses.
Medical subject headings
- Neurotoxicity Syndromes
- Thalidomide